Echocardiography in Patients With Covid-19

NCT04412460 | Withdrawn

• 1 other identifier: CovidEcho
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

Prospective observational study of patients treated due to Covid-19 disease. Observation and analysis of echocardiographic studies performed in the intensive care setting.

Conditions

COVID; ARDS, Human

Outcome Measures

Primary Outcomes (1)

• ICU Mortality

  up to 90 days

Secondary Outcomes (3)

• ICU length-of stay

  up to 90 days

• ICU ventilator free days

  up to 90 days

• Hospital length-of-stay

  up to 90 days

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults admitted for ICU therapy due to severe Covid-19

You may qualify if:

• Age above 18 years
• Covid-19 disease
• invasive Ventilation

You may not qualify if:

• none

Sponsors & Collaborators

• University Hospital Tuebingen: lead

Study Sites (1)

University Hospital Tubingen

Tübingen, Baden-Wurttemberg, 72076, Germany

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung Diseases; Respiratory Tract Diseases; Respiration Disorders

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 20, 2020
• First Posted: June 2, 2020
• Study Start: March 20, 2020
• Primary Completion: December 31, 2021
• Study Completion: December 31, 2021
• Last Updated: September 30, 2021

Record last verified: 2020-05

Data Sharing

• IPD Sharing: Will not share

Locations

DE (1)